TWO DEVICES. ENDLESS IMPACT.
Don’t guess! See the two biggest barriers to healing in real time.
SnapshotNIR + SnapshotGLO = clarity in care.
PORTABLE BACTERIA ASSESSMENT
*
PORTABLE BACTERIA ASSESSMENT *
SNAPSHOTGLO IS HERE! non-invasively assesses bacterial bioburden at the bedside.
REAL WORLD EVIDENCE STUDY
*
REAL WORLD EVIDENCE STUDY *
SnapshotNIR USED on 4,000+ wounds to deliver targeted care & improve healing outcomes
Better Clinical Decisions.
Better Together.
SnapshotNIR and SnapshotGLO work together to reveal two key barriers to healing—low tissue oxygenation and elevated bacterial bioburden. With dual imaging insights, clinicians gain clarity, confidence, and speed in decision-making, supporting earlier, more targeted interventions that optimize treatment, reduce delays, and help protect against complications.
Better data. Better outcomes. Better together.
September 28, 2026
CONNECT AT SAWC FALL!
Kent Imaging is attending SAWC-Fall at booth 530, October 15-18. Come see SnapshotNIR and SnapshotGLO and connect with our team.
August 27, 2026
KENT X MARATHON MEDICAL
New partnership with Marathon Medical Corporation, a Veteran-Owned Small Business specializing in federal healthcare distribution.
SNapshot Suite: Bioburden Reduction and Improved Tissue Oxygenation in Fungating Melanoma Wound
Tyler Sexton, MD, MAPWCA
The Snapshot Suite revealed a substantial bacterial burden that was not visible through routine clinical assessment, demonstrating the limitations of visual inspection alone. Following conservative wound cleansing, SnapshotGLO confirmed near-complete bioburden eradication, while SnapshotNIR showed improved tissue oxygenation. By providing objective, real-time feedback on both bacterial burden and tissue oxygenation, the Snapshot Suite helps clinicians validate treatment effectiveness and make more confident, informed decisions at the point of care.
WOUND CARE
RECONSTRUCTIVE SURGERY